Effect of Liraglutide on Long-Term Weight Maintenance Following Weight Loss Induced by a 12-Week Low-Calorie Diet in Obese Subjects; A 52 Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Trial With a 12 Week Follow-up Period.

Trial Profile

Effect of Liraglutide on Long-Term Weight Maintenance Following Weight Loss Induced by a 12-Week Low-Calorie Diet in Obese Subjects; A 52 Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Trial With a 12 Week Follow-up Period.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity
  • Focus Pharmacodynamics; Registrational; Therapeutic Use
  • Acronyms SCALE; SCALE-Maintenance
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 20 May 2017 Results of a post-hoc analysis comparing outcomes in liraglutide 3.0 mg early responders vs. early non-responders who completed 56 weeks of treatment, presented at the 24th European Congress on Obesity.
    • 04 Apr 2016 Results (pooled analysis of this and other four trials, n = 5338) assessing neuropsychiatric Safety Profile presented at The 98th Annual Meeting of the Endocrine Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top